Genomic research holds incredible promise for improving human health, but one major challenge has slowed its progress: confusion over reference sequences. These sequences serve as blueprints for ...
insights from industryDr. George EmanuelCo-Founder and Sr. Director of Technology & PartnershipsVizgen In this interview, we speak to Dr. George Emanuel, Scientific Co-Founder at Vizgen, about their ...
The many advances that have propelled the field of genetics forward have taken a tremendous amount of work in different fields. While some researchers have devised better reagents or bench protocols, ...
Genetic editing is an invaluable tool in biomedical research. Scientists have been able to engineer the genomes of a variety of animals, including fruit flies, zebrafish, and mice, to model diseases ...
Commercial structural genomics aims to capitalize upon, and extend, the recent flood of genomic sequence and expression information, translating it into a form that is directly applicable to target ...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an ...
A University of Virginia School of Medicine scientist and collaborators have developed a much-needed new tool to increase the efficiency of genomic research and accelerate the development of new ways ...
StockStory.org on MSN
10x Genomics (TXG) stock is up, what you need to know
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...
In addition to advancing research and potentially accelerating new treatments, the new tool could help improve cancer diagnosis. UVA Health researchers have developed an important new tool to help ...
NEW YORK, NY (April 22, 2019) - A new technique called ECCITE-seq, developed by scientists at the New York Genome Center's (NYGC) Technology Innovation Lab (@NYGCtech), allows researchers to perform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results